Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Cancers
|
February 4, 2021
Measles Virus as an Oncolytic Immunotherapy
Christine E Engeland, Guy Ungerechts
Pathogens (Basel, Switzerland)
|
March 27, 2024
The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics
Assia Angelova, Jean Rommelaere, Guy Ungerechts
Mabs
|
November 8, 2021
Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics
Roland E Kontermann, Guy Ungerechts, Dirk M Nettelbeck
Expert Opinion on Biological Therapy
|
January 14, 2015
Gene and cell therapy for pancreatic cancer
Hans Martin Singh, Guy Ungerechts, Apostolia M Tsimberidou
Lancet (London, England)
|
September 20, 2025
Oncolytic viruses as anticancer agents: clinical progress and remaining challenges
Elizabeth Appleton, E Antonio Chiocca, Guy Ungerechts, et al.
Cancers
|
August 10, 2024
H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment Immune Modulation in a Novel Heterotypic Spheroid Model of Cutaneous T-Cell Lymphoma
Assia Angelova, Milena Barf, Alexandra Just, et al.
Ebiomedicine
|
May 5, 2018
Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy
Carole Achard, Abera Surendran, Marie-Eve Wedge, et al.
Cancer Research
|
August 4, 2006
Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases
Christoph Springfeld, Veronika von Messling, Marie Frenzke, et al.
Nucleic Acids Research
|
May 8, 2026
Development of a tetracycline-inducible programmed ribosomal frameshifting platform for sensitive regulation of mammalian gene expression
Sıla Köse, Elisabeth Müller, Pierre Gommeringer, et al.
Cytokine & Growth Factor Reviews
|
July 29, 2020
Engineering and combining oncolytic measles virus for cancer therapy
Mathias F Leber, Serge Neault, Elise Jirovec, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Cancers
|
February 4, 2021
Measles Virus as an Oncolytic Immunotherapy
Christine E Engeland, Guy Ungerechts
Pathogens (Basel, Switzerland)
|
March 27, 2024
The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics
Assia Angelova, Jean Rommelaere, Guy Ungerechts
Mabs
|
November 8, 2021
Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics
Roland E Kontermann, Guy Ungerechts, Dirk M Nettelbeck
Expert Opinion on Biological Therapy
|
January 14, 2015
Gene and cell therapy for pancreatic cancer
Hans Martin Singh, Guy Ungerechts, Apostolia M Tsimberidou
Lancet (London, England)
|
September 20, 2025
Oncolytic viruses as anticancer agents: clinical progress and remaining challenges
Elizabeth Appleton, E Antonio Chiocca, Guy Ungerechts, et al.
Cancers
|
August 10, 2024
H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment Immune Modulation in a Novel Heterotypic Spheroid Model of Cutaneous T-Cell Lymphoma
Assia Angelova, Milena Barf, Alexandra Just, et al.
Ebiomedicine
|
May 5, 2018
Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy
Carole Achard, Abera Surendran, Marie-Eve Wedge, et al.
Cancer Research
|
August 4, 2006
Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases
Christoph Springfeld, Veronika von Messling, Marie Frenzke, et al.
Nucleic Acids Research
|
May 8, 2026
Development of a tetracycline-inducible programmed ribosomal frameshifting platform for sensitive regulation of mammalian gene expression
Sıla Köse, Elisabeth Müller, Pierre Gommeringer, et al.
Cytokine & Growth Factor Reviews
|
July 29, 2020
Engineering and combining oncolytic measles virus for cancer therapy
Mathias F Leber, Serge Neault, Elise Jirovec, et al.
Page
of 6